These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 117654)

  • 1. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and properties of a highly purified Clostridium botulinum type F toxin].
    Uvarova RN; Reshetnikova LN; Ispolatovskaia MV; Bulatova TI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):42-6. PubMed ID: 7004005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An immunochemical study of serologically active substances isolated from Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):10-8. PubMed ID: 4969441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunochemical study of Clostridium botulinum type B toxin].
    Kliucheva VV; Saprykina TP; Mironova MV; Vlagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Sep; (9):57-62. PubMed ID: 6795866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular structure and immunochemical properties of highly purified hemagglutinin from Clostridium botulinum type A].
    Ivanova LG; Blagoveshchenskiĭ VA; Vinogradova ID; Kolesnikova VA; Ugriumova GA
    Biokhimiia; 1983 Sep; 48(9):1548-54. PubMed ID: 6414537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparative separation of toxin and prototoxin from CL. botulinum type B cells].
    Ivanova LG; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):115-8. PubMed ID: 4218008
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular construction of Clostridium botulinum type A toxins.
    Sugii S; Sakaguchi G
    Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of progenitor toxins of nonproteolytic with those of proteolytic Clostridium botulinum Type B.
    Miyazaki S; Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1976 Mar; 13(3):987-9. PubMed ID: 818020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncorrelation between mouse toxicity and serologically assayed toxin in Clostridium botulinum type A culture fluids.
    Betley MJ; Sugiyama H
    Appl Environ Microbiol; 1979 Aug; 38(2):297-300. PubMed ID: 391153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative immunochemical study of the hemagglutinins of Cl. botulinum A and B].
    Ivanova LG; Kliucheva VV; Blagoveshchenskiĭ VA; Lebedenko GI; Saprykina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):48-53. PubMed ID: 404806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.